VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
1.420
+0.040 (2.90%)
At close: Jul 11, 2025, 4:00 PM
1.400
-0.020 (-1.41%)
After-hours: Jul 11, 2025, 7:44 PM EDT
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $23.66 million as of July 11, 2025. Its market cap has decreased by -5.85% in one year.
Market Cap
23.66M
Enterprise Value
-26.54M
1-Year Change
-5.85%
Ranking
Category
Stock Price
$1.42
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $23.66M, a decrease of -89.70%. That is a compound annual growth rate of -34.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 23.66M | -52.11% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | 265.25M | 15.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.45B |
| Johnson & Johnson | 376.02B |
| AbbVie | 336.71B |
| Novo Nordisk | 308.58B |
| UnitedHealth Group | 274.78B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 231.78B |
| AstraZeneca | 218.25B |